Stock MDGE.F MEDIGENE AG
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Medigene AG OTC Markets

Equities

MDGE.F

DE000A1X3W00

Market Closed - OTC Markets
Other stock markets
 10:36:56 2024-03-28 EDT 		5-day change 1st Jan Change
2.297 USD -11.96% Intraday chart for Medigene AG -5.49% +53.10%
07-03 Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China CI
06-27 Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness CI

Evolution of the average Target Price on Medigene AG

Price target over the last 5 years

History of analyst recommendation changes

d1.wWXf4wm11GKdRm7f7bDpENL5oNR1uJ-uE-IdHSNFvZI.jVC6t0qYuhfYI1u7pfSwdLvI0eJG69bhQ5ckWVQC5Me2EJPSUPuuG_RrXg~b235a719654f7a3f6e32a31a612f1123

Analyst Recommendations on Medigene AG

MEDIGENE AG : Baader Bank reaffirms its Neutral rating ZD
Berenberg Goldman Sachs German Corporate Conference FA
MEDIGENE AG : Baader Bank revises his opinion and turns to Neutral ZD
Berenberg and Goldman Sachs German Corporate Conference FA
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.18 EUR
Average target price
2.675 EUR
Spread / Average Target
+126.69%
High Price Target
3 EUR
Spread / Highest target
+154.24%
Low Price Target
2.35 EUR
Spread / Lowest Target
+99.15%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Medigene AG

BAADER BANK Bruno Bulic
INDEPENDENT RESEARCH Stefan Röhle

Ratings for Medigene AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MDG1 Stock
  4. MDGE.F Stock
  5. Consensus Medigene AG